Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington's Disease in The Lancet Neurology
- Statistically Significant Improvement in Chorea Associated with Huntingtons Disease Seen as Early as Week 2 - Chorea Improvement Supported by Statistically...
United States Eiryw Roberts Neurocrine Biosciences Erin Furr Stimming Mcgovern Medical School Department Of Neurology
Source: prnewswire.com